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To further investigate the molecular basis underlying the dysregulation of B cell homeostasis associated with bovine
leukemia virus disease progression in cattle, bovine bax was cDNA cloned and sequenced. The predicted amino acid
sequence of bovine Bax revealed a 192-amino-acid protein having extensive identity with the human (97%), murine (93%), and
rat (94%) homologues. Because the ratio of Bcl-2 to Bax is believed to predetermine the susceptibility to a given apoptotic
stimulus, the relative expression of the genes encoding these oncoproteins was evaluated in cattle naturally infected with
BLV. In BLV-infected cattle an increase in the ratios of bcl-2/bax mRNA and protein expression correlated with advancing
stages of disease. These findings suggest that in addition to the maintenance of BLV-associated hematopoietic malignancies,
the reciprocal expression of Bcl-2/Bax may modulate the induction of B cell expansion typical of BLV disease progression.
© 1998 Academic Press
INTRODUCTION
Bovine leukemia virus (BLV) is a B-lymphocytotropic
retrovirus closely related by genomic organization and
disease progression to human T cell leukemia virus
type-1 (HTLV-1) (reviewed by Franchini, 1995; Kettmann
et al., 1994). Infection by BLV is characterized by a long
clinical latency and a persistent immune response asso-
ciated with low level or transient viral expression (Haas
et al., 1992; Jensen et al., 1991). Approximately 65% of
infected cattle remain clinically and hematologically nor-
mal with B cells harboring provirus accounting for 0 to
18% of the peripheral blood mononuclear cells (PBMC)
(Mirsky et al., 1996). In ;30% of BLV-infected cattle, a
persistent nonneoplastic accumulation of B lymphocytes
(persistent lymphocytosis [PL]), representing 46 to 65% of
the total PBMC population, occurs without a concomitant
increase in the absolute number of uninfected B cells
(Mirsky et al., 1996). In less than 5% of infections, a fatal,
monoclonal, neoplastic transformation of B lymphocytes
appears, resulting in lymphocytic leukemia (LL) or ma-
lignant lymphoma (ML). In cattle with LL, the PBMC
consist almost exclusively of BLV-infected neoplastic B
cells, whereas cattle with ML typically exhibit normal
hematological profiles despite having solid tumors com-
prised of BLV-infected B lymphocytes. Because the risk
of developing LL/ML is greater in cattle with PL than in
BLV-seropositive cattle with normal hematological pa-
rameters, PL may represent a preneoplastic condition
(Ferrer et al., 1979; Kettmann et al., 1980).
Similar to the etiopathogenesis of HTLV-1 in humans,
the development of BLV-associated hematopoietic ma-
lignancies represents a violation in cellular homeostasis.
The maintenance of cellular homeostasis reflects a bal-
ance between cell proliferation and cell death. Increased
proliferation or prolonged survival of infected cells may
explain the dysregulation of B cell homeostasis associ-
ated with BLV disease progression. However, in vitro
studies in our laboratory have shown that the progres-
sive B cell expansion associated with BLV infection rep-
resents a suppression of programmed cell death (apop-
tosis) and increased expression of the bcl-2 protoonco-
gene (manuscript submitted). Although Bcl-2 is known to
promote cell survival (reviewed by Yang and Korsmeyer,
1996) the mechanism by which this protein and its ho-
mologs control the apoptotic pathway remains unknown.
Bax, a conserved homologue to Bcl-2, counters the death
repressor activity of Bcl-2 and can accelerate apoptosis
(Oltvai et al., 1993). Recent studies suggest that the
relative ratios of Bcl-2 to Bax, rather than the singular
expression of either protein, can prescribe survival or
death to diverse apoptotic stimuli (Oltvai and Korsmeyer,
1994; Thomas et al., 1996).
Because BLV infection in cattle represents an estab-
lished model for the study of analogous human retroviral
associated diseases, this system is ideal to investigate
the interplay between viral infection and the modulation
of effectors of apoptosis in the development of hemato-
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poietic malignancies. In this study, we have identified,
cDNA cloned, and sequenced the bovine homologue of
the bax protooncogene. Furthermore, we extend our pre-
vious findings by demonstrating a progressive increase
in the ratio of bcl-2/bax expression associated with B
cell accumulation and leukemogenesis in BLV-infected
cattle.
RESULTS
Cloning and characterization of bovine baxa
Northern blot analysis was used to determine the
major bax species present within the calf thymus RNA
utilized to synthesize the bovine cDNA library. A ribo-
probe complementary to amino acids 25 to 118 (span-
ning exons 3 and 4) of human bax detected an intense
1.0-kb and a minor 1.5-kb transcript (Fig. 1). These tran-
scripts correspond in size to those encoding the mem-
brane-associated a and cytosolic b isoform of bax, re-
spectively (Oltvai et al., 1993). A single 1.0-kb transcript
was detected in control cell line 729 RNA.
Characterization of the original bovine cDNA library
revealed an approximate frequency of clones containing
the bax coding domain of 1 per 8 3 106. Enzymatic
enrichment increased this frequency to 1 per 500, allow-
ing the independent isolation of two cDNA clones en-
coding the entire bovine baxa major open reading frame
(ORF). DNA sequence analysis of these clones revealed
a 576-bp ORF flanked by 49-bp of 59 and 217-bp of 39
noncoding sequence (Fig. 2). The methionine initiation
codon for this cDNA occurs in a strong context, conform-
ing to a Kozak consensus motif (Kozak, 1996) which is
identical to the translational initiation sequence for hu-
man bax (Oltvai et al., 1993). Based on the neighbor-
joining method for reconstructing phylogenetic trees
(Saituo and Nei, 1987), the bovine baxa ORF displayed
95, 89, and 90% identity with the human, murine (Oltvai et
al., 1993), and rat (Tilly et al., 1995) homologues, respec-
tively. Similarly, the predicted amino acid sequence of
bovine Baxa revealed 97, 93, and 94% respective identity
with the human, murine, and rat proteins.
Reciprocal expression of bax and bcl-2 correlates
with disease progression in BLV-infected cattle
C-RT-PCR was used to evaluate the relative expres-
sion of bax and bcl-2 mRNA in cattle in various stages of
BLV infection. The oligonucleotide primer sets used in
this assay were positioned to detect the a integral mem-
brane forms as well as the cytosolic b species of bax
and bcl-2. Figure 3A illustrates the specificity of the
C-RT-PCR protocol for the simultaneous detection of bax
(a 1 b) and bcl-2 (a 1 b) mRNA.
This protocol was used to determine the ratio of bcl-
2/bax transcriptional activity in 44 cattle (10 BLV2, 10
BLV1, 10 BLV1/PL, and 14 BLV1/LL/ML). As shown in
Fig. 3B, there was a significant, progressive increase in
the ratio of bcl-2/bax mRNA with advancing stages of
BLV-associated disease. In PBMC isolated from 3 of 10
BLV-infected cattle with the preneoplastic condition of
PL, an increase in bcl-2/bax mRNA expression relative to
nonneoplastic PBMC was detected. Standard regression
analysis showed no correlation between bcl-2/bax
mRNA expression and total PBMC counts in cattle with
PL (R 5 0.248, P 5 0.4889). Increased ratios of bcl-2/bax
expression were also observed in neoplastic lympho-
cytes isolated from 10 of 14 cattle with LL or ML relative
to PBMC derived from BLV2, BLV1, or PL cattle. Further-
more, the bcl-2/bax mRNA expression within tumor cells
was uniformly greater than in nonneoplastic PBMC de-
rived from the same cattle with ML.
Relative levels of bax and bcl-2 translational activity
were examined using Western blot analysis. As shown in
Fig. 4A, proteins corresponding in size to Baxa (21 kDa)
(Oltvai et al., 1993) and Bcl-2a (26 kDa) (Tsujimoto and
Croce, 1986; Tsujimoto et al., 1987), respectively, were
detected within both neoplastic and nonneoplastic bo-
vine tissues using anti-human gene-specific antibodies.
The differential expression of Bax and Bcl-2 between
these tissues, which were isolated from a single cow
with ML, is representative of the pattern of increased
Bcl-2/Bax protein ratios associated with BLV-induced
malignancy (Fig. 4B). Similar antibody specificities were
observed from the analysis of human 729 cell line protein
lysates; however, human Bax showed a minor decrease
in electrophoretic mobility relative to the bovine Bax
homologue (data not shown). Additionally, a minor 17-
FIG. 1. Detection of bax mRNA by Northern blot hybridization. Poly-
adenylated RNA was analyzed from bovine calf thymus and the human
cell line 729. Positions of the 28S and 18S ribosomal RNAs and RNA
molecular weight markers are shown.
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19-kDa protein analogous to the g isoform of Bax de-
scribed by Krajewski et al. (1994) was detected in human
729 cell line lysates (data not shown) but was absent in
all bovine tissues examined. Analysis of 33 cattle (7
BLV2, 7 BLV1, 13 BLV1/PL, and 6 BLV1/LL/ML) revealed
a pattern of increasing Bcl-2/Bax ratios with advancing
stages of BLV-associated disease, similar to that ob-
served for the transcriptional activity of bax and bcl-2
(Fig. 4B). Moreover, segregation of cattle with PL from
hematologically normal cattle was more dramatic based
on Bcl-2/Bax protein ratios than measurement of mRNA
expression. These differences in ratios of bcl-2/bax
mRNA, compared to protein expression, may reflect
steps in the transcriptional and translational control of
these protooncogenes. Comparable ratios of Bcl-2/Bax
were detected in PBMC isolated from BLV2 cattle, from
BLV1 cattle with normal hematological parameters, and
in nonneoplastic PBMC from cattle with ML. Fewer cattle
were included in the analysis of Bcl-2/Bax protein ratios
than for the evaluation of the relative expression bcl-2/
bax mRNA because of limitations in tissue availability.
DISCUSSION
The mechanisms which control apoptosis have not
been completely defined; however, it is evident that this
universal process is regulated by a genetic program
involving both effectors and repressors (Hale et al., 1996).
FIG. 2. Comparison of bovine and human Baxa. The nucleotide and predicted amino acid sequence of bovine Baxa are aligned for maximum
homology with human Baxa Distances from the amino terminus of both proteins are given on the right. Only those residues of the human protein
which are divergent from bovine Bax are shown. Hyphens represent identical amino acid residues between both proteins.
186 REYES AND COCKERELL
Among the regulators of apoptosis, the Bcl-2 protein
family is unique by virtue of its action on a distal step in
an evolutionary conserved pathway (Reed et al., 1996).
Many viral proteins have been shown to regulate apop-
tosis through the modulation of Bcl-2 expression or by
encoding proteins with similar functions to this proto-
oncogene. Among the Retroviridae, endogenously ex-
pressed Tat and Tax of the human immunodeficiency
virus type-1 and HTLV-1, respectively, have been shown
to inhibit activation-induced apoptosis through the regu-
lation of Bcl-2 expression (Copeland et al., 1994; McClos-
key et al., 1997). Similarly, we have previously demon-
strated increased expression of BLV tax mRNA (Reyes
and Cockerell, 1996) as well as bcl-2 mRNA and protein
(manuscript submitted) in lymphocytes isolated from
BLV-infected cattle with P or LL/ML, compared to hema-
tological normal cattle. Although both Bcl-2 and Bax
function to maintain cellular homeostasis, few studies
have investigated the role of Bax in virally induced leu-
kemogenesis. A recent report showing in vitro repres-
sion of the human bax promoter by HTLV-1 Tax (Brau-
weiler et al., 1997) suggests that BLV may influence the
expression of the Bax protein.
To investigate the potential role of Bax in BLV-induced
disease, the bovine homologue of this repressor of pro-
grammed cell death was cDNA cloned and sequenced.
The predicted amino acid sequence of bovine bax
shares strong phylogenetic homology with the human
and murine Bax proteins (Oltvai et al., 1993). Moreover,
the hypothetical ‘‘suicide domain’’ comprising residues
55–77 of Bax (Hunter and Parslow, 1996) is identical
between these species. Rueda et al. (1997) recently de-
scribed a partial cDNA sequence of bovine bax encoding
a protein fragment (residues 36–169) with greater diver-
gence from human Bax than the predicted amino acid
sequence described in the present study. These discrep-
ant results may reflect sequence anomalies within the
partial cDNA which was derived from a single RT-PCR
fragment (Rueda et al., 1997). Cross-reactivity of the anti-
human Bax antibody with bovine cellular lysates rein-
forces our findings of minimal divergence between hu-
man and bovine Bax (97% similar) since this antibody
fails to recognize the more divergent murine protein (93%
similar). Interestingly, the human and bovine bax mRNA
transcripts are 98% similar over the 59 noncoding se-
are presented as ratios of bcl-2/bax mRNA. The BLV infection and
disease status of each category of cattle are shown below the ab-
scissa. Nonneoplastic PBMC isolated from cattle with ML are desig-
nated as ML*. Datum points represent the average results obtained
from individual cattle analyzed in triplicate. Heavy horizontal bars rep-
resent the mean value of each data set. Letters adjacent to the mean
values indicate statistical significance: a, different from BLV2 (P 5
0.0326), BLV1 (P 5 0.0246), BLV1/LL/ML (P 5 0.0003); b, different from
BLV2 (P , 0.0001), BLV1 (P , 0.0001), BLV1/PL (P 5 0.0003), BLV1/
ML* (P , 0.0001).
FIG. 3. Estimation of bax and bcl-2 transcriptional activity using
C-RT-PCR. (A) Demonstration of C-RT-PCR specificity by Southern blot
hybridization. All blots contain identical C-RT-PCR reaction products.
Blots were hybridized with oligonucleotide probes specific for bax
(5HBAX166) and bcl-2 (BP) as shown across the top. Amplified products
are identified on the left. (B) Relative levels of bcl-2 and bax expression
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quence shown in Fig. 2 and encode a NotI restriction site
located 49 bp proximal to the methionine initiation
codon. Since this enzyme was used to construct the calf
thymus cDNA library, the bovine bax cDNA clones de-
scribed in the present study do not contain the theoret-
ical transcription start site which has been mapped to
position 2372 in the human gene (Miyashita and Reed,
1995a).
It has been established that both Bax and Bcl-2 play
important roles in the apoptotic pathway and that rela-
tive, rather than absolute, levels of these proteins deter-
mine the susceptibility to a given apoptotic stimulus
(Oltvai and Korsmeyer, 1994). Our data demonstrating an
increase in the ratios of bcl-2/bax mRNA and protein in
neoplastic lymphocytes from BLV-infected cattle are sim-
ilar to findings in humans with B cell chronic lymphocytic
leukemia (Pepper et al., 1996). The wide distribution of
bcl-2/bax mRNA and protein expression in lymphocytes
derived from BLV-infected cattle with LL/ML or humans
with B cell chronic lymphocytic leukemia may reflect
progression through the hypothetical model of molecular
cell death checkpoints proposed by Oltvai and Kors-
meyer (1994). This suggestion is supported by our finding
of increased bcl-2/bax mRNA and protein in PBMC from
cattle with the preneoplastic condition of PL. These re-
sults argue that in addition to the maintenance of BLV-
associated hematopoietic malignancies, the reciprocal
expression of Bax/Bcl-2 may modulate the induction of B
cell expansion typical of BLV disease progression.
In this study, we evaluated the relative expression of
bax and bcl-2 in nonneoplastic, preneoplastic, and neo-
plastic tissues, containing unequal populations of B and
T cells. Our results show increased expression of bcl-2,
relative to bax, in preneoplastic PBMC from cattle with
PL and neoplastic lymphocytes from cattle with LL or ML.
As a result of infection with BLV, these tissues are bio-
logically enriched in B cells. Interestingly, immunoblot
analysis of normal human PBMC have demonstrated
relatively high levels of Bax protein in B cells, compared
to T cells, whereas expression of Bcl-2 was high in both
cell phenotypes (Ohta et al., 1995). Furthermore, multi-
color flow cytometric analysis has shown comparable
levels of Bcl-2 protein among peripheral B and T lympho-
cytes (Aiello et al., 1992). These studies indicate that the
relative expression of bcl-2/bax is greater in normal
FIG. 4. Estimation of Baxa and Bcl-2a protein expression by Western
blot hybridization. The BLV infection and disease status of each cate-
gory of cattle analyzed is shown above or below each figure. Nonneo-
plastic PBMC isolated from cattle with ML are designated as ML*. (A)
Demonstration that anti-human antibodies detect Baxa and Bcl-2a in
bovine tissue lysates. Protein molecular weight markers are identified
on the left. Arrows indicate the positions and sizes of Baxa and Bcl-2a.
(B) Relative levels of Baxa and Bcl-2a expression are presented as a
ratio of Bcl-2a/Baxa. Datum points represent the average results ob-
tained from individual cattle analyzed in triplicate. Heavy horizontal
bars represent the mean value of each data set. Letters adjacent to the
mean values indicate statistical significance: a, different from BLV2
(P 5 0.0038), BLV1 (P 5 0.0010), BLV1/LL/ML (P 5 0.0056), BLV1/ML*
(P 5 0.0304); b, different from BLV2 (P 5 0.0001), BLV1 (P , 0.0001),
BLV1/PL (P 5 0.0056), BLV1/ML* (P 5 0.0001).
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peripheral T than in B cells. Taken together, our findings
suggest that differences in the expression of bax and
bcl-2 within BLV-infected and noninfected lymphocytes
reflect an association between the modulation of these
oncoproteins and BLV.
Recent reports have shown that bax is a p53 primary
response gene (Miyashita and Reed, 1995b) and that
transcriptional activation of bax by p53 is associated with
a simultaneous decrease in the steady-stage levels of
bcl-2 mRNA and protein. Using a transgenic mouse
model in which p53-mediated apoptosis attenuates tu-
mor growth, Yin et al., demonstrated that Bax is required
for half of the p53-dependent apoptosis in choroid plexus
epithelium (Yin et al., 1997). Interestingly, HTLV-1 Tax has
been shown to suppress the expression of p53 (Uitten-
bogaard et al., 1995). Additionally, mutations in p53 have
been associated with BLV-induced malignancies in cat-
tle (Dequiedt et al., 1995). These findings illustrate the
complexity of the pathways which regulate cellular ho-
meostasis and their potential vulnerability to viral disrup-
tion.
The results of the present study demonstrate the value
of cattle naturally infected with BLV and in well-defined
stages of disease, as an animal model for analogous
retroviral-induced disease in humans and to delineate
the interplay between regulators of cellular homeostasis.
Furthermore, the bovine baxa cDNA and deduced pro-
tein sequence reported here provides additional infor-
mation on conserved residues within the Bcl-2 protein
family which should be useful in future studies to delin-
eate their role as mediators of programmed cell death.
MATERIALS AND METHODS
Animals and cell lines
Adult Holstein female cattle from commercial dairies
were classified as BLV-seropositive (BLV1) or -seroneg-
ative (BLV2) based on the presence or absence of anti-
bodies against BLV gp51 by using an agar gel immuno-
diffusion assay (Leukassay B; Rhone Merieux, Inc., Ath-
ens, GA). Cattle were categorized as having PL if their
lymphocyte counts exceeded 9.5 3 103/ml on consecu-
tive evaluations at ^3-month intervals. Solid tumor tis-
sues were collected from cattle with ML at surgery or
immediately following euthanasia and processed by
manual disruption (Jensen et al., 1991) to obtain single-
cell suspensions. PBMC and single-cell suspensions of
tumor tissues were purified by density gradient centrifu-
gation on Ficoll–Hypaque (Histopaque 1077; Sigma
Chemical Co., St. Louis, MO). Thymic tissue from a 17-
day-old Holstein male calf was used to generate the
bovine cDNA library. Following collection, all tissues
were either processed immediately or maintained at
270°C until use. The Epstein–Barr virus-transformed hu-
man B lymphoblastoid cell line, 729 (Glassy et al., 1983),
was used as a source of control RNA and protein.
RNA isolation
Total cellular RNA was isolated using TRIzol reagent
(Life Technologies, Gaithersburg, MD) and treated with
RNase-free DNasel. Polyadenylated RNA was enriched
from total cellular RNA using oligo(dT) cellulose as pre-
viously described (Celano et al., 1993).
Cloning of bovine bax
Reverse transcription–PCR (RT-PCR) with oligonucleo-
tides derived from the human bax sequence was used to
amplify a 280-bp fragment from calf thymus RNA. Ampli-
fication was performed by incubating 0.5 mg total RNA
with 50 pmol each of primers 5HBAX75 and 3HBAX353
(Table 1) at 75°C for 10 min. The reaction was subse-
quently cooled at 0°C for 10 min and combined with 1 U
of Prime RNase inhibitor (5 Prime3 3 Prime, Inc., Boul-
der, CO), 10 mM Tris–HCl (pH 8.3), 50 mM KCl, 1.75 mM
MgCl2, 0.2 mM deoxyribonucleoside triphosphates
(dNTPs), 4 U of Avian myeloblastosis virus reverse tran-
scriptase (Promega, Madison, WI), and 2 U of Taq poly-
merase (Boehringer Mannheim Corp., Indianapolis, IN),
in a total volume of 50 ml. The RT-PCR temperature
profile consisted of 46°C for 45 min, 95°C for 3 min, 23
cycles of 94°C for 30 s, 69°C (decreasing 1°C each
cycle) for 20 s, and 72°C for 20 s, and 17 cycles of 94°C
for 30 s, 46°C for 20 s, and 72°C for 20 s. The 280-bp
product was cloned into the pCRII vector (Invitrogen, San
Diego, CA) and sequenced using the ABI 377 dye termi-
nator sequencing system (Perkin Elmer, Foster City, CA).
Based on this newly derived sequence, oligonucleotides
were synthesized to enrich and screen a cDNA library for
the bovine baxa gene.
A bovine cDNA library consisting of 9 3 105 primary
clones was previously prepared from calf thymus RNA
using the SuperScript plasmid cDNA system (Life Tech-
TABLE 1
Sequence and Positions of Oligonucleotide Primers and Probes
Primer or
probe Sequence (59 3 39) Nucleotide position
5HBAX75 TTTGCTTCAGGGTTTCATCCAG 75-96a,b
3HBAX291 AGCTGCCACTCGGAAAAAGAC 291-271a,b
5HBAX166 ACCAAGAAGCTGAGCGAGTGTC 166-187a,b
3HBAX353 TGCTGGCAAAGTAGAAAAGGGC 355-334a,b
5BBAX72 CCTTTTGCTTCAGGGTTTCATCCAG 72-96a,b
3BBAX281 CAGAAAACATTTCAGCCGCCACTC 304-281b
3BBAX412 CGAAGGAAGTCCAATGTCCAGCC 434-412b
BCL54 TTCGCCGAGATGTCCAGTCAGC 304-325c
BCL34 TTGACGCTCTCCACACACATGACC 458-435c
BP AGGGGTCATGTGTGTGGAGAG 432-452c
a Nucleotide position in the human bax sequence (Oltvai et al., 1993).
b Nucleotide position in the bovine baxa sequence (see below).
c Nucleotide position in the bovine bcl-2 sequence (Submitted for
publication).
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nologies) (manuscript submitted) and was amplified on
solid medium. Following conversion of this library to
single-stranded phagemid DNA (Kunkel et al., 1991),
cDNA clones encoding bax were selectively reverted to
double-stranded molecules. Single-stranded library
cDNA (3mg) was combined in a total volume of 100 ml
with 0.1 mM oligonucleotide 3BBAX281 (Table 1), 20 mM
Tris–HCl (pH 8.8), 10 mM KCl, 10 mM (NH4)2SO4, 2 mM
MgSO4, 0.1% Triton X-100, 0.2 mM dNTPs, 1 U of Deep
Vent DNA polymerase (New England Biolabs Inc., Bev-
erly, MA), and incubated at 94°C for 5 min, 62°C for 1
min, and 68°C for 10 min. The resulting double-stranded,
nicked molecules were ligated for 10 min at 62°C with 2
U of Ampligase (Epicenter Technologies, Madison, WI),
and the residual single-stranded cDNA molecules re-
moved with mung bean nuclease (New England Biolabs).
The bax-enriched cDNA pool was then transformed into
Escherichia coli DH12S (Life Technologies) and was
screened using oligonucleotides 5HBAX75 and
3HBAX291 (Table 1) together with a dilutional PCR pro-
tocol as previously described (Alfandari and Darribere,
1994). Two clones containing the bovine baxa coding
domain were isolated and both strands of each clone
were sequenced using the ABI 377 dye terminator se-
quencing system with oligonucleotides 5HBAX75,
5HBAX166, 3HBAX291, and 3HBAX353 (Table 1) and the
M13 universal sequencing primers (Perkin Elmer). DNA
and protein sequence analysis was performed using the
Clustal V alignment package (European Molecular Biol-
ogy Laboratory, Heidelberg, Germany).
At each stage of the cDNA enrichment procedure, the
frequency of clones containing the bax coding domain
sequence was estimated. Serial dilutions of bacterial
clones were grown to saturation and assayed using PCR
with oligonucleotides 5HBAX75 and 3HBAX353.
Northern blot analysis
Polyadenylated RNA (4 mg/well) was separated on
1.5% agarose–0.66 M formaldehyde gels, transferred to
positively charged nylon (Magnacharge; Micron Separa-
tions Inc., Westborough, MA) and hybridized with 5 3
10210 M digoxigenin-labeled human bax riboprobe (see
below) in rapid hybridization buffer (Amersham, Arlington
Heights, IL). The membranes were blocked for 1 h at
37°C in 1% (w/v) Hammarsten casein (Gallard-Schlesen-
ger, Carle Place, NY), 0.05% Tween 20, 150 mM NaCl, 50
mM Tris–HCl (pH 7.8) (blocking buffer), and incubated at
27°C for 1 h with 1 3 1024 U/ml alkaline phosphatase-
conjugated anti-digoxigenin antibody (Boehringer Mann-
heim Corp.). Following four serial washes in blocking
buffer at 27°C for 15 min, hybridized RNA was visualized
using CSPD chemiluminescence substrate (Tropix, Bed-
ford, MA) according to the manufacturer’s instructions.
The bax riboprobe was constructed using RT-PCR with
oligonucleotide primers 5BBAX72 and 3BBAX412 (Table
1) to amplify a cDNA fragment encoding amino acids 25
to 118 of human bax from cell line 729 RNA. Reaction
conditions were as described above except that the
following temperature profile was used: 46°C for 45 min,
95°C for 3 min, 35 cycles of 94°C for 30 s, 60°C for 20 s,
and 72°C for 20 s. The product was cloned into the pCRII
vector (Invitrogen), and antisense RNA was transcribed
using the Ampliscribe System T7 (Epicenter Technolo-
gies), substituting 2.6 mM digoxigenin-11-UTP (Boehr-
inger Mannheim Corp.) and 4.9 mM unlabeled UTP for
the recommended 7.5 mM UTP in the final reaction mix-
ture.
C-RT-PCR
The relative levels of bax and bcl-2 transcriptional
activity were evaluated by comparative RT-PCR (C-RT-
PCR) using oligonucleotide pairs 5BBAX72-3BBAX281
and BCL54-BCL34 (Table 1) to coamplify bax and bcl-2
mRNA, respectively. Reaction conditions were as de-
scribed above except that the following temperature pro-
file was used: 46°C for 45 min, 95°C for 3 min, 7 cycles
of 94°C for 30 s, 69°C (decreasing 1°C each cycle) for
20 s, 72°C for 20 s, and 29 cycles of 94°C for 30 s, 62°C
for 20 s, and 72°C for 20 s. The specificity of bax and
bcl-2-amplified products was verified by Southern blot
hybridization using alkaline phosphatase-labeled oligo-
nucleotide probes 5HBAX166 and BP (Table 1), respec-
tively (Reyes and Cockerell, 1993). The relative ratios of
bax and bcl-2 mRNA in each sample were determined by
densitometric analysis of ethidium bromide-stained aga-
rose gels using an IS-1000 digital imaging system (Alpha
Innotech, San Leandro, CA). In each experiment, nega-
tive control reactions consisting of all the C-RT-PCR com-
ponents except for the target RNA were performed.
Western blot analysis of Bax and Bcl-2
Total cell lysates of PBMC and tumor tissues were
prepared as previously described (Tamaru et al., 1993),
diluted in Laemmli’s sample buffer (Laemmli, 1970), and
boiled for 2 min. Proteins (20 ml, 106 cells) were sepa-
rated by 12% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis and transferred to polyvinylidene difluo-
ride membranes. The membranes were blocked for 1 h
at 37°C in blocking buffer, followed by incubation for 1 h
at 27°C with 0.25 mg/ml mouse anti-human Bax (4F11;
Medical & Biological Laboratories CO., LTD, Nagoya,
Japan) and 0.25 mg/ml mouse anti-human Bcl-2 (124;
Dako Corp., Carpinteria, CA) antibodies. Following eight
serial washes in blocking buffer at 27°C for 15 min, 0.4
ng/ml alkaline phosphatase-conjugated goat anti-mouse
IgG (Calbiochem, Cambridge, MA) was added and the
membranes were incubated at 27°C for 45 min. Immu-
noreactive proteins were visualized using CDP-Star
chemiluminescence substrate (Tropix) according to the
manufacturer’s instructions. The relative ratios of Bax
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and Bcl-2 in each sample were determined by densito-
metric analysis of the autoradiographs using an IS-1000
digital imaging system.
Statistical analysis
The Kolmogorov-Smirnov test was used to determine
normality of the distribution of each data set. Differences
in the cellular expression of bcl-2/bax mRNA or protein
between categories of cattle were determined using a
multifactorial ANOVA followed by the Fisher’s least sig-
nificant difference post hoc test.
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